Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.25 USD | -0.51% | -0.79% | +25.00% |
Apr. 01 | Vapotherm, Inc. Enters into Amendment No. 7 to Loan and Security Agreement with SLR Investment Corp | CI |
Mar. 15 | Vapotherm, Inc. to Unveil Access365 Home Ventilation Solution at MEDTRADE | CI |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 345.8 | 256.4 | 689.3 | 540 | 72.11 | 6.138 |
Enterprise Value (EV) 1 | 322 | 230 | 628.5 | 536.3 | 161.6 | 108.8 |
P/E ratio | -1.36 x | -4.43 x | -12.4 x | -8.98 x | -0.64 x | -0.1 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 8.16 x | 5.33 x | 5.48 x | 4.77 x | 1.08 x | 0.09 x |
EV / Revenue | 7.6 x | 4.78 x | 5 x | 4.73 x | 2.42 x | 1.58 x |
EV / EBITDA | -9.22 x | -5.14 x | -16.5 x | -10.6 x | -2.26 x | -3.33 x |
EV / FCF | -10.4 x | -8.58 x | -23 x | -14.5 x | -2.71 x | -6.78 x |
FCF Yield | -9.63% | -11.6% | -4.35% | -6.9% | -36.9% | -14.7% |
Price to Book | 6.49 x | 4.72 x | 6.07 x | 8.12 x | -2.73 x | -0.11 x |
Nbr of stocks (in thousands) | 2,167 | 2,636 | 3,208 | 3,259 | 3,338 | 6,138 |
Reference price 2 | 159.6 | 97.28 | 214.9 | 165.7 | 21.60 | 1.000 |
Announcement Date | 3/22/19 | 3/4/20 | 2/24/21 | 2/24/22 | 2/23/23 | 2/22/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 42.38 | 48.1 | 125.7 | 113.3 | 66.8 | 68.67 |
EBITDA 1 | -34.94 | -44.79 | -38.04 | -50.59 | -71.61 | -32.71 |
EBIT 1 | -37.11 | -47.96 | -42.81 | -56.24 | -76.79 | -37.69 |
Operating Margin | -87.58% | -99.71% | -34.05% | -49.64% | -114.95% | -54.88% |
Earnings before Tax (EBT) 1 | -42.47 | -51.2 | -51.5 | -59.88 | -113.2 | -58.07 |
Net income 1 | -42.47 | -51.06 | -51.5 | -59.8 | -113.3 | -58.19 |
Net margin | -100.21% | -106.14% | -40.96% | -52.78% | -169.55% | -84.74% |
EPS 2 | -117.2 | -21.96 | -17.30 | -18.44 | -33.92 | -9.639 |
Free Cash Flow 1 | -31 | -26.79 | -27.33 | -36.99 | -59.67 | -16.04 |
FCF margin | -73.15% | -55.7% | -21.74% | -32.65% | -89.33% | -23.35% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 3/22/19 | 3/4/20 | 2/24/21 | 2/24/22 | 2/23/23 | 2/22/24 |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 |
---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 38.12 | 22.24 | 21.62 | 12.97 | 13.54 | 18.66 | 17.73 | 16.04 | 15.17 |
EBITDA 1 | -12.78 | -16.09 | -19.72 | -38.54 | -17.75 | -12.02 | -9.183 | -8.95 | -6.076 |
EBIT 1 | -12.88 | -17.98 | -19.93 | -39.84 | -22.92 | -17.7 | -13.14 | -10.16 | -10.27 |
Operating Margin | -33.8% | -80.84% | -92.19% | -307.13% | -169.18% | -94.86% | -74.09% | -63.33% | -67.72% |
Earnings before Tax (EBT) 1 | -13.57 | -18.64 | -22.85 | -42.69 | -26.21 | -21.5 | -18.08 | -14.76 | -15.11 |
Net income 1 | -13.57 | -18.56 | -22.94 | -42.68 | -26.2 | -21.44 | -18.09 | -14.79 | -15.13 |
Net margin | -35.59% | -83.44% | -106.09% | -329.06% | -193.44% | -114.86% | -102.02% | -92.21% | -99.76% |
EPS 2 | -4.160 | -5.680 | -6.960 | -12.88 | -7.840 | -6.240 | -3.600 | -2.320 | -2.380 |
Dividend per Share | - | - | - | - | - | - | - | - | - |
Announcement Date | 11/3/21 | 2/24/22 | 5/4/22 | 8/3/22 | 11/2/22 | 2/23/23 | 5/3/23 | 8/8/23 | 11/8/23 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | 89.5 | 103 |
Net Cash position 1 | 23.7 | 26.4 | 60.8 | 3.63 | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | -1.249 x | -3.139 x |
Free Cash Flow 1 | -31 | -26.8 | -27.3 | -37 | -59.7 | -16 |
ROE (net income / shareholders' equity) | -110% | -97% | -61.4% | -66.2% | -589% | 139% |
ROA (Net income/ Total Assets) | -29.5% | -28.7% | -16.3% | -18.7% | -37.5% | -27.1% |
Assets 1 | 144.2 | 178.1 | 315.2 | 319.6 | 302.4 | 214.7 |
Book Value Per Share 2 | 24.60 | 20.60 | 35.40 | 20.40 | -7.910 | -8.970 |
Cash Flow per Share 2 | 27.80 | 27.50 | 35.40 | 17.50 | 4.420 | 1.580 |
Capex 1 | 5.18 | 4.75 | 9.8 | 5.9 | 11.6 | 2.99 |
Capex / Sales | 12.22% | 9.87% | 7.79% | 5.2% | 17.38% | 4.36% |
Announcement Date | 3/22/19 | 3/4/20 | 2/24/21 | 2/24/22 | 2/23/23 | 2/22/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+25.00% | 7.76M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- VAPO Stock
- Financials Vapotherm, Inc.